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Introduction 
Synthetic biology can be defined as the application of engineering principles to the 
fundamental components of biology. More precisely the UK Royal Society (Royal Society, 
s.a.) describes synthetic biology as follows:  
Synthetic biology is an emerging area of research that can broadly be described as the 
design and construction of novel artificial biological pathways, organisms or devices, 
or the redesign of existing natural biological systems. 
The European NEST High-Level Expert Group (2005) defines synthetic biology as follows: 
“Synthetic biology is the engineering of biology: the synthesis of complex, biologically 
based (or inspired) systems which display functions that do not exist in nature. This 
engineering perspective may be applied at all levels of the hierarchy of biological 
structures – from individual molecules to whole cells, tissues and organisms. In 
essence, synthetic biology will enable the design of ‘biological systems’ in a rational 
and systematic way.” 
The title of this article is derived from (de Lorenzo & Danchin, 2008) who described the 
current state at that time.  
The purpose of this investigation in descriptive informetrics is to explain the current situation 
of this emerging field. In order to extract the necessary information we performed a topic 
mining exercise in the Web of Science (WoS). The main step is the construction of a search 
query in order to catch the essential components of the field. Our query is more 
comprehensive and leads to better results than that used by Oldham, Hall and Burton (2012), 
described in the next section. The results of this query enable the detection of the most active 
countries/regions, continents and organizations. Not surprisingly the USA is the most active 
country and Mainland China is moving up the ranks, being second in the latest year. We 
further determine the WoS categories and areas to which articles on synthetic biology belong. 
It is shown that growth in terms of number of published articles per year follows an 
exponential curve. These aspects are of interest and form an essential part of the study of any 
emerging field, but they do not use any new technique. Yet for the study of the distribution of 
topic keywords we apply a recently introduced approach (Hu & Rousseau, 2014a) based on 
the idea of year-based h-indices (Mahbuba & Rousseau, 2013). Details of the method are 
provided further on.  It is found that protein engineering, metabolic engineering and protein 
design are the overall hot topics in synthetic biology.  
This article is an extended and reworked version of a preprint deposited in the arXiv (Hu & 
Rousseau, 2014b).  
A short history and review of the field 
The term synthetic biology was first introduced by the French scientist Stéphane Leduc 
(1912), be it with a different meaning as today’s, and according to Wikipedia 
(http://en.wikipedia.org/wiki/Synthetic_biology) in modern times by the Polish geneticist 
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Waclaw Szybalski in the year 1974 (Szybalski, 1974).  Although Wikipedia even provides a 
quote we were unable to find this quote in (Szybalski, 1974). To be precise, Szybalski does 
describe what we nowadays would call synthetic biology and writes “we enter the synthetic 
phase of research in the field” [i.e. of molecular biology]. Putting aside the question of who 
was first it is true that the term gained popularity and usage in mainstream science only in the 
year 2004 when the first international meeting, called Synthetic Biology 1.0, was held at MIT, 
USA (Jain, Bhatia & Chugh, 2012). Going back to Fleming’s discovery of penicillin (the first 
antibiotic with wide-spread use) Jain and her collaborators discuss the scope of synthetic 
biology for developing novel drugs. Envisaging loads of other applications scientists 
nowadays declare that they can do better than evolution (Schuster, 2013). Among other 
aspects, Schuster points to promising aspects for information storage, recalling a pilot study 
(Church, Gao & Kosuri, 2012) in which an entire book, including figures and a Java script, in 
total more than five megabit, were stored on a single DNA molecule. Goldman (2014) points 
out that the (near) completion of the Human Genome Project provided the impetus for 
significant disciplinary progress. Reviews on synthetic biology, from a field-specialist 
technical point of view, can be found e.g. in (Li & Vederas, 2009; Purnick & Weiss, 2009; 
Esvelt & Wang, 2013). Moreover, Purnick and Weiss (2009) as well as Esvelt and Wang 
(2013) provide a timeline of milestones in synthetic biology. 
The main article using informetric techniques to study the field of synthetic biology is the one 
by Oldham, Hall and Burton (2012). They explore the field to inform debates on the 
governance (related to the United Nations Convention on Biological Diversity) of the field. 
For this reason they focus on different visualizations. Based on WoS data they distinguish 
between two groups of articles: the core consisting of 1,255 publications and a group of 
articles citing the core leading to another 5,995 items. Searches were conducted in January 
2012. Their core was obtained by a topic search for “synthetic biology”, “synthetic genomics”, 
“synthetic genome” or “synthetic genomes”. Details are discussed further on when comparing 
their results with ours. We note though that Oldham, Hall and Burton (2012) observed the 
incipient diversification of synthetic biology into mammalian synthetic biology, cell free 
synthetic biology, chemical synthetic biology, genome engineering, genome-scale synthetic 
biology, and even more. They point out that this diversification is important for policy debates 
as synthetic biology may cease to be a ‘unitary’ object for policy action. 
Recently Goldman (2014) studied the related field of systems biology, using this field as an 
empirical example to explore changes in the disciplinary structure of a field. She works under 
the assumption that concepts from systems biology are transmitted by papers linked via 
journals to various disciplines (in practice WoS subject categories). Following Liu and 
Rousseau (2010) she notes that the subject categories of the journals publishing on a topic can 
be indicators of the breadth of disciplinary diffusion. She uses a bipartite network to explore 
connectivity, concretely betweenness centrality, among subject categories and journals. Over 
the period 2000-2011 the number of subject categories and the number of journals both 
increased, while the percentage of subject categories with betweenness centrality equal to zero 
decreased. Such a decrease did not occur for the percentage of journals with betweenness 
centrality equal to zero. By 2011 subject categories formed a single large component. The 
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whole structure can be characterized as a core; semi-periphery; periphery structure. 
Biotechnology & Applied Microbiology; Biochemistry & Molecular Biology; Computer 
Science; Mathematical & Computational biology; Biophysics, and Genetic & Heredity form 
the core. Pharmacology & Pharmacy: Toxicology; Immunology; Nutrition & Dietetics, and 
Neurosciences & Neurology are examples of intermediary fields belonging to the semi-
periphery. She notes that growth at the periphery occurs largely through interdisciplinary 
journals. A time study reveals that, over time, several clinical disciplines move toward the 
core. Immunology, Healthcare Sciences & Services and Oncology are examples of such 
categories. This movement illustrates the progress made by systems biology in translating 
theory to practice. As a specific example of the efforts to bridge theory and practice she 
mentions the creation of the human diseasome, linking genotype and phenotype (Goh et al., 
2007). Finally, she proposes a typology of journal roles in core bridges, intermediary bridges 
and reinforcers.  
 
Methods 
Construction of a search query 
As the retrieval language for the WoS is a keyword language, not based on a controlled 
vocabulary or a thesaurus we have to construct a specific search query, similarly to what has 
been done for the field of nanotechnology (Kostoff et al., 2006).  
The following methodology (synthesized in Figure 1) has been employed. 
(1) Essential records were retrieved using the term “synthetic biology” as a topic search in the 
Web of Science (in short: WoS): 
TS=”synthetic biology” and document type = article  
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2013. 
This search retrieved 1,333 records (date of retrieval: January 11, 2014). These were 
downloaded using the full record option. 
(2) Next, we extracted the “Keywords” and “Keywords Plus” from all 1,333 records, and 
obtained their frequencies. In this way 6,054 terms were found and ranked in descending 
order of occurrence.  
(3) We sought the precise meanings of the terms in this list making use of MeSH (Medical 
Subject Headings) definitions and descriptions in Wikipedia (http://en.wikipedia.org/). This 
led to a list of most-used content terms related specifically to synthetic biology.   
(4) We then used these content terms related to synthetic biology to expand the original 
query, leading to the final search string: 
TS= ("synthetic biology" OR "synthetic gene network*" OR biobrick* OR "protein design*" 
OR "genetic circuit*" OR "gene regulatory network*" OR "cell-free protein synthes*” OR 
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“metabolic engineering" OR "protein engineering” OR “promoter engineering” OR “DNA 
assembly” OR “RNA engineering biosensors” OR “multipart DNA assembly” OR “sequential 
circuits” OR “benchmark synthetic circuits” OR “DNA nanotechnology” OR “human 
artificial chromosome” OR “synthetic promoters” OR “transcriptional circuits” OR “abstract 
genetic regulatory network*” OR “gene assembly” OR “post-transcriptional regulation” OR 
“engineered proteins” OR “cell-free gene circuits”) AND Document Types=(Article) 
Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH Timespan=2000-2013. 
 
FIG. 1. Search strategy for finding articles about synthetic biology 
In this way, 13,836 records were obtained. This set is the main focus of this article. Yet, in 
order to broaden the view on the field of synthetic biology we also performed  three other 
searches (in December 2014): first a search in PubMed with “synthetic biology” as a MeSH 
term. However, as this term was only introduced since the year 2011, this led to a small set of  
821 journal articles. For this reason we used the search string constructed for the WoS in the 
“advance search” of PubMed (http://www.ncbi.nlm.nih.gov/pubmed/advanced). Note though 
that this leads to a search in the title/abstract field (not to a complete topic search). In this way, 
we retrieved 12,028 journal articles published during the period 2000-2013. Finally, we 
queried MEDLINE via the Web of Knowledge 
(WoK)(https://apps.webofknowledge.com/MEDLINE_GeneralSearch ).  This approach has a 
better search interface and provides a search field for “topic search”. Again using the same 
search string we retrieved 27,208 journal articles published in the time span 2000 - 2013.  All 
records were downloaded for further analysis. Table 1 synthesizes our search results. 
      
 Table 1. Search results by different interfaces 
 Search query Time span Records 
PubMed/MeSH  Synthetic biology as MeSh term 2011-  821 
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PubMed/advanced Search string applied to 
title/abstract  
2000-2013 12,028 
MEDLINE/WoK  Search string as a topic search 2000-2013 27,208 
WoS Search string as a topic search 2000-2013 13,836 
 
We further note that when searching MEDLINE entry terms are automatically mapped to the 
corresponding descriptors. This is an advantage for practitioners, but not for bibliometricians, 
as it is not immediately clear which terms are included.  
We note that Goldman (2014) only used the topic search term “systems biology” in the WoS 
and included all publication types, leading to 4,446 publications over the period 2000 through 
2011. This is a major difference between our approach and Goldman’s.  
As the field of synthetic biology is said to hold great promise for commercialization we also 
performed a search for patents in the Derwent Innovations Index (DII), using a similar search 
query as in the WoS. The search was performed on January 24, 2014 in the Databases: 
CDerwent, EDerwent and MDerwent, and for the Timespan=2000-2013. This resulted in 788 
patent records. 
Data processing 
- Topic keyword counting. We determined the keyword frequency based on the retrieved 
13,836 records from the WoS search, and their yearly distribution. 
- Dynamic study of keyword use. To find out the major keywords in this field and their 
changes in frequency over the period 2000-2013, we calculate the value for the highly 
frequent keywords using the recently introduced “year based h-type indices” (Mahbuba & 
Rousseau, 2013; Hu & Rousseau, 2014). 
 
Results and basic data 
In this section we show basic results: most active countries/regions, continents and 
organizations; WoS categories and areas to which articles on synthetic biology belong; 
number of articles per year and aspects of growth. Most data were obtained by using WoS’ 
analyze function. Table 2 shows a list of most-cited articles in the field of synthetic biology 
according to the WoS.  
Table 2. Most cited articles in the domain of synthetic biology (WoS results). 
Authors  Source Publication year Times cited 
Baba, T.,  et al.  Molecular Systems Biology, 2, 
article number 2006.0008 
2006 1654 
Gardner, TS., et al Nature, 403(6767), 339-342 2000 1379 
Ren, B., et al Science, 290(5500), 2306-2309 2000 1197 
Mattoussi, H., et al. Journal of the American Chemical 2000 1134 
7 
 
Society, 122(49), 12142-12150 
Xie, XH., et al Nature, 434(7031), 338-345 2005 1065 
Zheng, M., et al. Science, 302(5650), 1545-1548 2003 953 
Chen, JF., et al. Nature Genetics, 38(2), 228-233 2006 855 
Kuhlman, B., et al. Science, 302(5649), 1364-1368 2003 627 
Canutescu, AA., et al. Protein Science, 12(9), 2001-2014 2003 618 
Wei, CL., et al Cell, 124(1), 207-219 2006 585 
 
We abbreviate the term Synthetic Biology referring to the set of articles retrieved by our WoS 
query as SB. 
Most-active countries/regions over the period  2000 – 2013 are shown in Table 3. We added 
the leading country in Africa (South Africa) and Bangladesh, as an example of a developing 
country and because of previous interest in it (Mahbuba & Rousseau, 2010). Recall that the 
WoS assigns an article to each country with at least one participating author as shown by 
his/her institutional address. Besides rankings over the whole period we also show number of 
publications and rankings for the first and the second half of the period. Moreover, we 
calculated the percentage of articles about synthetic biology among all articles (over the same 
period) and the ranking (restricted to the 27 countries/regions studied here) according to this 
parameter.  
Table 3. Most-active countries/regions over the period  2000 – 2013, data from the WoS. 
Rank Country # 
articles 
% SB and 
ranking 
# publications and 
ranking 
2000 – 2007 
# publications and 
ranking 
2008-2013 
1 USA 5973 0.144 (2) 2419 (1) 3554 (1) 
2 GERMANY 1392 0.129 (5) 504 (3) 888 (3) 
3 JAPAN 1294 0.125 (7) 630 (2) 664 (4) 
4 PEOPLES R 
CHINA 
1258 0.092 (16) 263 (5) 995 (2) 
5 ENGLAND 966 0.101 (13) 347 (4) 619 (5) 
6 FRANCE 621 0.080 (19) 244 (6) 377 (6) 
7 CANADA 553 0.088 (17) 224 (7) 329 (8) 
8 SOUTH KOREA 508 0.119 (8) 164 (9) 344 (7) 
9 ITALY 442 0.074 (21) 182 (8) 442 (10) 
10 SPAIN 410 0.083 (18) 128 (12) 282 (9) 
11 NETHERLANDS 385 0.110 (11) 164 (9) 221 (11) 
12 SWITZERLAND 346 0.136 (3) 143 (11) 203 (12) 
13 AUSTRALIA 301 0.069 (23) 109 (14) 192 (14) 
14 INDIA 300 0.069 (24) 105 (15) 195 (13) 
15 SWEDEN 279 0.113 (9) 110 (13) 169 (15) 
16 DENMARK 208 0.149 (1) 83 (16) 125 (18) 
17 ISRAEL 195 0.129 (4) 57 (19) 138 (17) 
18 TAIWAN 184 0.070 (22) 41 (20) 143 (16) 
19 SCOTLAND 158 0.106 (12) 35 (22) 123 (19) 
20 FINLAND 156 0.126 (6) 75 (17) 81 (22) 
21 BELGIUM 147 0.076 (20) 64 (18) 83 (21) 
22 AUSTRIA 128 0.096 (14) 40 (21) 88 (20) 
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23 SINGAPORE 109 0.112 (10) 31 (27) 78 (23) 
24 RUSSIA 102 0.028 (27) 35 (22) 67 (24) 
25 BRAZIL 99 0.031 (26) 38 (22) 61 (27) 
 SOUTH AFRICA 
(38) 
28 0.033 (25) 12 (36) 16 (41) 
 BANGLADESH 
(52) 
10 0.096 (15) 3 (49) 7 (53) 
 
China and to a lesser extent Singapore, South Korea, Taiwan and Austria moved up in the 
rankings when comparing the second period to the first one. Among the top countries Japan 
lost two positions in the rankings. The ranking according to the percentage of articles devoted 
to Synthetic Biology shows that, on the one hand, Denmark, Israel, Finland and Singapore 
have a high percentage of articles on SB, and even Bangladesh ranks 15th. On the other hand 
China, although ranking second in the second period is only 16th in the ranking per percentage 
devoted to SB, illustrating the fact that China has many other priorities. Also Canada, France, 
Italy and Spain have other priorities. Compared with the results of Oldham, Hall and Burton 
(2012) we notice several differences: UK is second in their core group, Switzerland 5th, Spain 
6th, Japan 8th and China 10th. Yet, in the citing articles group China becomes 4th. 
Divided over continents we obtain the results shown in Table 4. Note that because whole 
counting has been used the sum (17,648) is more than the real total (13,836), hence we show 
results as percentages of the total (and even then results should be interpreted as 
approximations). Russia is considered to be a part of Europe, not for geographical reasons 
(then it would be part of Asia) but because most research is performed in the European part of 
Russia. North America consists of Canada and the USA, while the other countries of the 
Americas are referred to as Latin America. Compared with the total output of the world 
Africa’s share is smaller than 1%. Clearly Europe and North America keep each other in 
balance, while Asia is the upcoming third. 
Table 4. Shares per continent 
Continent Share (in %) 
Europe 37 
North America 37 
Asia 22 
Latin America 2 
Oceania 2 
 
Most active organizations are shown in Table 5. This list is clearly dominated by American 
universities, but since the day we collected the data CAS has overthrown MIT as the most-
active organization. Yet, this list has no clear top university or small group of top 
organizations but numbers decrease slowly. We further note that the first company in this list 
is Genentech Inc. on rank 185 with 27 articles. This seems to indicate that, although synthetic 
biology can be considered an applied field it is not yet a field which is ripe for large scale 
commercialization.   
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Table 5. Most-active organizations 
Organization # articles 
MIT (USA) 244 
CHINESE ACAD SCI (P.R. China) 242 
HARVARD UNIV (USA) 242 
CALTECH (USA) 228 
STANFORD UNIV (USA) 221 
UNIV TOKYO (JPN) 203 
UNIV CALIF BERKELEY (USA) 197 
DUKE UNIV (USA) 148 
UNIV WASHINGTON (USA) 147 
UNIV ILLINOIS (USA) 138 
 
Again Oldham, Hall and Burton (2012) obtain different results. Their list of most-active 
organizations consists of the University of California Berkeley, the Swiss Federal Institute of 
Technology (ETH), Harvard and MIT. We found 121 articles for ETH. Clearly, as already 
shown on country level, China and Japan are underrepresented in their investigation, while, 
moreover, our results are more recent. 
Delving somewhat deeper into this we also performed a search for patents in the Derwent 
Innovations Index (DII), using a similar search query as in the WoS. Contrary to article 
publishing institutions, patent assignees are mostly Japanese and Korean, see Table 6. Yet 
numbers of assigned patents are an order of magnitude less than numbers of publications, 
confirming the observation that the field is not yet ripe for large-scale commercialization. No 
Chinese company belongs to this list. 
Table 6. Most-active assignees (from the DII search) 
Assignee Name # patents 
CELLFREE SCI KK (=CO LTD) (JP) 25 
MACROGEN CO LTD (Korea) 23 
DOKURITSU GYOSEI HOJIN RIKAGAKU 
KENKYUSH (JP) 
17 
SHIMADZU CORP (JP) 17 
TOYOBOSEKI KK (JP) 17 
MASSACHUSETTS INST TECHNOLOGY 
(MIT) (USA) 
12 
NEC ELECTRONICS CORP (JP) 12 
UNIV LOUISIANA STATE & AGRIC & MECH 
COLL (USA) 
10 
RIKEN KK (JP) 10 
UNIV CALIFORNIA (USA) 9 
 
The multidisciplinary aspects of SB are clearly shown by the WoS categories involved in its 
research. Table 7 shows the top-10 categories, together covering about 63% of all articles. Yet, 
in total 173 WoS categories are involved. As many journals belong to more than one category 
the ten categories shown in Table 7 already add up to more than 100%.  Also Oldham et al. 
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(2012) have Biochemistry & Molecular Biology as leading subject category (core and citing 
articles), followed by Chemistry (for the citing articles group) and Biotechnology & Applied 
Microbiology (second in the core). We observe that Chemistry and Goldman’s (2014) core 
category Computer Science are not included in our list. The reason is that we used Web of 
Science categories, while Oldham, Hall and Burton (2012) and Goldman probably used so-
called research areas (but write that they use subject categories). Computer Science as a 
research area consists of several Web of Science categories such as: Computer Science 
Interdisciplinary Applications; Computer Science Hardware Architecture and Computer 
Science Theory & Methods. A similar observation holds for Chemistry. Moreover a different 
approach was used: we and Oldham, Hall and Burton just counted articles, while Goldman 
applied network centrality indicators. Finally, we used a more inclusive search query. 
 
Table 7. WoS categories most involved in SB research 
WoS categories % of all articles 
BIOCHEMISTRY & MOLECULAR BIOLOGY 31.9 
BIOTECHNOLOGY & APPLIED MICROBIOLOGY 21.7 
MULTIDISCIPLINARY SCIENCES 9.1 
BIOCHEMICAL RESEARCH METHODS 8.0 
MATHEMATICAL & COMPUTATIONAL BIOLOGY 6.7 
CELL BIOLOGY 6.6 
BIOPHYSICS 6.1 
CHEMISTRY MULTIDISCIPLINARY 5.3 
GENETICS & HEREDITY 5.1 
PLANT SCIENCES 4.1 
 
Using the five main research domains of the Web of Science we obtain the following 
percentages per domain: see Table 8. 
Table 8. Distribution per large domain 
Research domain percentage 
Life sciences & biomedicine 74.37 
Technology 14.89 
Physical sciences 9.94 
Social sciences 0.57 
Arts & humanities 0.24 
 
As MEDLINE covers more journals in medicine and the life sciences than the WoS we drew 
a list of journals publishing the most articles within the field of synthetic biology from data 
obtained from this database (see Table 9). 
Table 9. Twenty journals publishing the most articles on synthetic biology (period 2000-2013); 
data from MEDLINE/WoK. 
11 
 
Source # records 
PLOS ONE 1202 
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF 
THE UNITED STATES OF AMERICA 
716 
THE JOURNAL OF BIOLOGICAL CHEMISTRY 562 
NUCLEIC ACIDS RESEARCH 532 
METHODS IN MOLECULAR BIOLOGY CLIFTON N J 449 
BIOTECHNOLOGY AND BIOENGINEERING 410 
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY 409 
JOURNAL OF BIOTECHNOLOGY 400 
JOURNAL OF MOLECULAR BIOLOGY 399 
BIOINFORMATICS OXFORD ENGLAND 345 
PROTEIN ENGINEERING DESIGN SELECTION PEDS 333 
METABOLIC ENGINEERING 325 
BMC SYSTEMS BIOLOGY 313 
BMC BIOINFORMATICS 308 
BMC GENOMICS 301 
BIOCHEMISTRY 294 
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 288 
APPLIED AND ENVIRONMENTAL MICROBIOLOGY 266 
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 259 
CURRENT OPINION IN BIOTECHNOLOGY 259 
 
 
 
Research in synthetic biology is often supported by grants from large funding bodies. The 
WoS yields a list of 8,455 names, be it that there are many funds occurring under several 
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names. Table 10 shows the most-important ones: NIH USA has more than 1000 supported 
articles, while the other ones have each at least 200 supported articles. 
Table 10. Most important funding organizations 
National Institutes of Health (NIH) - USA 
National Science Foundation (NSF) - USA 
National (Natural) Science Foundation China 
European Union (EU) / European Commission (EC) 
Deutsche Forschungsgemeinschaft (DFG) 
 
Oldham et al.’s list of funding institutes is dominated by the NIH, NSF(USA) and the 
European Programs. Again, China’s research (funded by NSFC) is underrepresented in their 
study. 
Doing better than evolution has a touch of “playing god” and certainly entails moral 
obligations and ethical problems, see e.g. (Renn & Roco, 2006) for a discussion of similar 
problems in the field of nanotechnology. Adding the topic terms “ethic*” OR “moral*” to the 
main query led to 54 articles. The largest group (17) is in the WoS Category Ethics, followed 
by Social Sciences Biomedical (12). Six articles are published in Environmental Values and 
five in Bioethics. More than half were published in the latest two years. 
Growth in the number of articles on synthetic biology 
The yearly growth curve based on the WoS query is shown in Figure 2. This curve can best be 
described as exponential growth. Giving the year 2000 the x-value 0 (and hence 2013 the x-
value 13) a best-fitting curve is given by y = 454.3 e0.105x (R2 = 0.97), where y denotes the 
yearly number of published articles on synthetic biology.  
 
FIG. 2. Growth in the number of published articles (WoS data) 
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This analysis provides an opportunity to compare WoS data with PubMed data. Figure 3 
shows the growth in number of published articles according to MEDLINE/WoK. Also these 
data lead to an exponential growth with a best-fitting curve given by y = 535.1 e0.148x (R2 = 
0.99). Although our MEDLINE search retrieved considerably more records than the WoS 
search the corresponding growth curves show a similar trend.  
 
FIG. 3 Growth in the number of published articles (MEDLINE data) 
Distribution of topic keywords, year-based h-indices   
We found a total of 22,253 keywords in the retrieved WoS records. Keywords-PLUS were not 
included as they are in most cases too general, i.e. not specific for the field of synthetic 
biology. However, the majority of the keywords (16,905 terms or 76%) occurred just once, 
reflecting the broadness of the field, as well as the fact that, being in an emerging stage, 
terminology has not yet settled. Remarkably, the term synthetic biology (and related terms) 
occurred just 28 times (period 2000-2013) proving that we had to look into the field’s “world” 
rather than just considering the “word”. Focusing on major topics we brought keywords and 
related forms together under one name. In this way we obtained 35 highly frequent topic-
related keywords each occurring at least 100 times. We removed general topics such as cell, 
enzyme, genetic, gene, protein, escherichia coli and their related terms, leading to 28 
keywords, representing the hot, specific topics in the field of synthetic biology. These 
keywords were analyzed using a recently introduced approach based on year-based h-indices 
(Mahbuba & Rousseau, 2013). 
We recall the following definitions from (Hu & Rousseau, 2014). Consider a given topic term 
T and assume that years (here restricted to the period 2000-2013) are ranked according to the 
number of articles published dealing with this topic. Then this topic’s year-based h-index is 
equal to t if t is the highest rank such that in the first t years t articles were published dealing 
with this topic (because of the period used, this h-index can at most be equal to 14). Let Z and 
Y be the latest and the oldest years included in the topic’s h-core, then the period [Y, Z] is 
called the core interval. If Z-Y+1 = t then there is no gap in the core. The core gap is defined 
as Z-Y+1-t, or informally: the number of missing years in the core. Finally, the relative core 
14 
 
gap for topic T is defined as: (core gap / t). In (Hu & Rousseau, 2014) we have shown how 
using these notions may provide an easy-to-use overview of a field, concretely: molecular 
research in nervous system diseases. Table 10 shows the results of the analysis of the SB set, 
based on year-based h-indices. 
Table 10.  Hot topic keywords in the research field of synthetic biology and their year-based 
activity h-type indices during the period 2000-2013 
Topic keywords Year-based 
h-index 
Core 
interval Top year Core gap 
Relative 
core gap 
protein engineering 14 2000-2013 2011 0 0 
metabolic engineering 14 2000-2013 2013 0 0 
protein design+* 14 2000-2013 2012 0 0 
DNA+ 11 2002-2013 2013 1 0.09 
microRNA+ 10 2002-2013 2013 2 0.2 
cell-free protein synthesis+ 10 2004-2013 2007 0 0 
protein folding+ 10 2000-2011 2004 2 0.2 
RNA+ 9 2003-2013 2012 2 0.22 
mutagenesis+ 9 2004-2013 2002 1 0.11 
gene expression+ 9 2002-2013 2013 3 0.33 
stability+ 9 2004-2013 2013 1 0.11 
fluorescence+ 9 2001-2013 2013 4 0.44 
protein stability+ 9 2001-2013 2004 4 0.44 
gene regulatory network+ 8 2006-2013 2012 0 0 
directed evolution+ 8 2005-2013 2012 1 0.125 
nano+ 8 2005-2013 2013 1 0.125 
evolution+ 8 2003-2013 2013 1 0.125 
systems biology+ 8 2004-2013 2012 2 0.25 
microarray+ 8 2006-2013 2012 0 0 
sequential circuit+ 8 2000-2008 2000 1 0.125 
biocatalysis+ 7 2005-2013 2013 2 0.29 
combination+ 7 2002-2013 2013 5 0.71 
gene regulation+ 7 2005-2013 2013 2 0.29 
self-assembly+ 7 2007-2013 2012 0 0 
antibody+ 7 2002-2013 2013 5 0.71 
dynamics+ 7 2007-2013 2012 0 0 
protein-protein interaction+ 7 2006-2013 2013 1 0.14 
genome+ 6 2006-2013 2012 2 0.33 
*The symbol “+”indicates a keyword and its related terms 
 
Clearly, protein engineering, metabolic engineering and protein design are the overall hot 
topics in synthetic biology. Oldham, Hall and Burton (2012) found the following top terms: 
synthetic biology, E. coli (a term we removed), gene expression, systems biology and 
metabolic engineering. Table 10 shows that the core interval of most topics extends to the 
latest year, namely 2013. Moreover, the top year (year in which the most articles on this topic 
were published) is often 2012 or 2013, indicating that the interest in these topics is still 
growing. Interest in sequential circuits seems to have passed its peak.  
Conclusion 
We believe that the innovative domain of synthetic biology may become a bigger 
interdisciplinary domain than nanoscience and nanotechnology. Clearly it is one of the 
battlefields where leading countries fight for the supremacy in science (Joyce,  Mazza & 
Kendall , 2013).  In terms of countries and institutes the USA is still leading the field, but 
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Mainland China is a strong and upcoming second. The word synthetic biology hides a large 
world ready to be explored by interdisciplinary research collaborations. We hope that this 
informetric study brings a new perspective to the study of synthetic biology.  
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